Earnings Release Schedules, Study Publications, and Annual Report Filing Updates - Analyst Notes on Align, Alere, Haemonetics, Hanger, and Hill-Rom

NEW YORK, April 7, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding Align Technology Inc. (NASDAQ: ALGN), Alere Inc. (NYSE: ALR), Haemonetics Corp. (NYSE: HAE), Hanger Inc. (NYSE: HGR), and Hill-Rom Holdings, Inc. (NYSE: HRC). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

--

Align Technology Inc. Analyst Notes 

On April 1, 2014, Align Technology, Inc. (Align) announced the schedule of the Company's Q1 2014 earnings release. The Company informed that it will report its Q1 2014 financial results on April 23, 2014, after the close of the market at 4:00 p.m. ET / 1:00 p.m. PT, which will be available at the Company's website under Investor Relations section. Align stated that in conjunction with its earnings release, the Company will host a conference call discussing its results at 4:30 p.m. ET/1:30 p.m. PT on the same day, which will be webcast live via the Internet over its website. The full analyst notes on Align Technology Inc. are available to download free of charge at:

http://www.AnalystsReview.com/04072014/ALGN/report.pdf

--

Alere Inc. Analyst Notes 

On March 24, 2014, Alere, Inc. (Alere) announced the publication of the largest-ever study of warfarin patient self-testing. According to Alere, the study demonstrated that weekly International Normalized Ratio (INR) testing significantly improves control of warfarin, as measured by time in therapeutic range (TTR), compared to a variable testing frequency. The Company informed that the results of the Self-Testing Analysis Based on Long-Term Experience (STABLE) study, which was supported by Alere, were published in the American Journal of Managed Care. The full analyst notes on Alere Inc. are available to download free of charge at:

http://www.AnalystsReview.com/04072014/ALR/report.pdf

--

Haemonetics Corp. Analyst Notes 

On April 1, 2014, Haemonetics Corp. (Haemonetics) reported that it will release Q4 FY 2014 and full-year FY 2014 financial results on April 28, 2014 in a pre-market press release. The Company stated that it will also provide its financial guidance for FY 2015 in the release. Haemonetics added that it will hold a webcast to discuss the results and answer questions related to the release on the same day at 8:00 a.m. EDT. The full analyst notes on Haemonetics Corp. are available to download free of charge at:

http://www.AnalystsReview.com/04072014/HAE/report.pdf

--

Hanger Inc. Analyst Notes 

On March 24, 2014, Hanger, Inc. (Hanger), formerly Hanger Orthopedic Group, Inc., announced that filing of Form 10-K for the year ended December 31, 2013 is in progress. The Company stated that as previously announced by it, Hanger has disclosed in its Form 12b-25 filed with the Securities and Exchange Commission (SEC) that it is unable to timely file its Annual Report on Form 10-K because of the additional time required to complete the testing and assessment of internal controls, which includes the testing and assessment of the updated controls and procedures. Hanger further announced that it has received a notice from the New York Stock Exchange (NYSE) that the Company is not in compliance with the NYSE's continued listing requirements. The Company informed that will be given time until September 17, 2014, to file its Form 10-K with the SEC, under the NYSE rules. Hanger stated that it can, and intends to, regain compliance with the NYSE listing standards prior to such date by filing the Form 10-K with the SEC. The full analyst notes on Hanger Inc. are available to download free of charge at:

http://www.AnalystsReview.com/04072014/HGR/report.pdf

--

Hill-Rom Holdings, Inc. Analyst Notes 

On April 2, 2014, Hill-Rom Holdings, Inc. (Hill-Rom) reported its plans to hold a conference call discussing its Q2 FY 2014 financial results on May 2, 2014, Friday, from 8:00 a.m. to 9:00 a.m. ET. The Company added that its earnings release will be issued the same morning before the conference call and will be available at the Company's website. Hill-Rom stated that the slide deck of the webcast of the call will be posted to the Company website prior to the webcast. The full analyst notes on Hill-Rom Holdings, Inc. are available to download free of charge at:

http://www.AnalystsReview.com/04072014/HRC/report.pdf

--

About Analysts Review
We provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

--

=============

EDITOR NOTES: 

• This is not company news. We are an independent source and our views do not reflect the companies mentioned.
• Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
• This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
• If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] AnalystsReview.com.
• For any urgent concerns or inquiries, please contact us at compliance [at] AnalystsReview.com.
• Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] AnalystsReview.com for consideration.

COMPLIANCE PROCEDURE 

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Analysts Review in this article or report according to the Procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE 

Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED 

Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

http://AnalystsReview.com

SOURCE Analysts Review